EMA
approval
· 2012-11-16
European Medicines Agency recommends approval of first vaccine for meningitis B
Summary
The EMA recommends approval of the first vaccine targeting meningitis B to prevent meningococcal disease caused by Neisseria meningitidis serogroup B.
Upgrade for the full analysis, importance score, and drug timeline.